Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer

Abstract

A substantial proportion of women with early-stage breast cancer may be suboptimally adherent to adjuvant anastrozole therapy. Future research should focus on the identification of patients at risk for nonadherence with oral hormonal therapy for breast cancer and the development of interventions to improve adherence.